CXCL9 and peripheral arterial disease: Additionally, our findings highlight the role of CXCL9, which inhibits collagen accumulation in human pulmonary artery smooth muscle cells through its interaction with the chemokine receptor CXCR3 (28), suggesting a mechanistic pathway that may influence PAD development.